Cullinan Therapeutics, Inc. ($CGEM)
Filing Information
| Accession Number | 0001193125-26-098781 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 9, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
16,000
Total Value
$142,640.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | Mar 5, 2026 | Exercise/Conversion | 4,000 | $4.30 | $17,200.00 | 178,844 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Mar 5, 2026 | Sale | 8,000 | $15.68 | $125,440.00 | 170,844 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Mar 5, 2026 | Exercise/Conversion | 4,000 | $0.00 | $0.00 | 120,987 | Direct | โ | View Details |